Back to top

FOURTH AMENDMENT TO THE LICENSE AGREEMENT BETWEEN VERNALIS DEVELOPMENT LIMITED AND ENDO PHARMACEUTICALS INC.

License Agreement

FOURTH AMENDMENT TO THE LICENSE AGREEMENT BETWEEN 

VERNALIS DEVELOPMENT LIMITED 

AND 

ENDO PHARMACEUTICALS INC. | Document Parties: ENDO PHARMACEUTICALS HOLDINGS INC | VERNALIS DEVELOPMENT LIMITED | VERNALIS DEVELOPMENT LTD You are currently viewing:
This License Agreement involves

ENDO PHARMACEUTICALS HOLDINGS INC | VERNALIS DEVELOPMENT LIMITED | VERNALIS DEVELOPMENT LTD

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: FOURTH AMENDMENT TO THE LICENSE AGREEMENT BETWEEN VERNALIS DEVELOPMENT LIMITED AND ENDO PHARMACEUTICALS INC.
Date: 2/26/2008
Industry: Biotechnology and Drugs     Sector: Healthcare

FOURTH AMENDMENT TO THE LICENSE AGREEMENT BETWEEN 

VERNALIS DEVELOPMENT LIMITED 

AND 

ENDO PHARMACEUTICALS INC., Parties: endo pharmaceuticals holdings inc , vernalis development limited , vernalis development ltd
50 of the Top 250 law firms use our Products every day

Exhibit 10.48.5

CONFIDENTIAL TREATMENT REQUESTED

The confidential portions of this exhibit have been filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities and Exchange Act of 1934 as amended. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN ***.

FOURTH AMENDMENT TO THE LICENSE AGREEMENT BETWEEN

VERNALIS DEVELOPMENT LIMITED

AND

ENDO PHARMACEUTICALS INC.

DATED JULY 14, 2004

This Fourth Amendment to the License Agreement by and between Vernalis Development Limited (“Vernalis”) and Endo Pharmaceuticals Inc. (“Endo”) (the “Fourth Amendment”) is, except as otherwise set forth herein, effective as of February 19, 2008.

WHEREAS, Vernalis and Endo entered into a License Agreement dated July 14, 2004, as amended by a letter agreement dated January 31, 2005, by a Second Amendment dated as of December 12, 2005 and by a Third Amendment dated as of July 23, 2007 (the “License”) whereby Vernalis licensed to Endo certain rights to the Product (as defined in the License); and

WHEREAS, Vernalis and Endo wish to further amend the License to address recent regulatory developments in relation to the MAM Product and the termination of the Loan Agreement and Security Agreement.

NOW THEREFORE, for good and valuable consideration the receipt of which is hereby acknowledged, the parties hereto agree as follows:

 

1. Unless set forth herein, the capitalized terms contained in this Fourth Amendment shall have the meanings set forth in the License.

 

2. The text of each of Clauses 1.1.21, 1.1.40, 1.1.57, 1.1.67, 1.1.89, 1.1.109, 3.1(iii), 6.1.1, 6.1.4, 6.2.1, 6.2.5 and 9 shall be deleted in its entirety.

 

3. Clause 3.2.3 shall be deleted in its entirety and replaced with the following:

“Endo shall not be restricted from appointing distributors, contract sales organizations, advertisers, public relations agencies or advisors to assist Endo with Commercialising the Product in the Territory.”

 

4. Clause 7.2 shall be modified by deleting the first sentence thereof and replacing it with the following:

“The SC shall hold meetings in person as frequently as the Members may agree shall be necessary during the period of thi


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more